Clinical trial
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Low Back Pain Clinical Study
NCT01835756 is registered in ClinicalTrials.gov with Erchonia Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Low Back Pain Clinical Study
- Lead sponsor
- Erchonia Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- September 30, 2014
- Enrollment
- 62 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.